Kelly M. Standifer, Ph.D.

Chair, Prof. of Pharmacology and Richard Anderson Chair

Department of Pharmaceutical Sciences

Phone (405) 271-6593 x47333

Fax (405) 271-7505

Office CPB 329

Email kelly-standifer@ouhsc.edu


Education & Experience

B.S. in Zoology

Duke University, Durham, NC

1984

Associate Natural Science in Natural Science

St. Gregory's College, Shawnee, OK

1982

Ph.D.

University of Florida, Gainesville, FL

1988


Publications & Presentations

1 2 3 4 > >>
  • Ibach B W, Miller J L, Woo S, Harrison D, Standifer K, Hagemann T M, Johnson P N. Characterization of tolerance in children during fentanyl continuous infusions. J Pediatr Intensive Care. 2017; 6 : 83-90
  • Standifer K M, Schalo I. [Phe1psi(CH2-NH)-Gly2]nociceptin-(1-13)-NH2. Elsevier. 2016
  • Awwad H O, Durand C D, Gonzalez L P, Tompkins P, Zhang Y, Lerner M R, Brackett D J, Sherry D M, Awasthi V, Standifer K. Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions. Behavioural brain research. 2016
  • Standifer K M, Simpson-Durand C. Nociceptin/Orphanin FQ. Elsevier. 2016
  • Standifer K M. Nociceptin/Orphanin FQ 1-13-NH2. Elsevier. 2016
  • 1 2 3 4 > >>